July 25th 2024
Patient factors trended towards an association with a higher risk of proliferative sickle cell retinopathy but did not reach statistical significance.
July 24th 2024
Giroctocogene fitelparvovec achieved primary and key secondary objectives of superiority compared to routine prophylaxis in hemophilia A treatment.
July 19th 2024
A study found individuals with type 2 diabetes who received less than 7 hours of sleep had 2.6 increased odds of microvascular disease.
July 18th 2024
The XTEND-Kids phase 3 trial shows efanesoctocog alfa’s safety and efficacy in children with severe hemophilia A, reducing bleeds with once-weekly dosing.
July 14th 2024
A study from the ASH Research Network reports positive antibody response and tolerability after mRNA vaccination in people with sickle cell disease.
Allogenic HSCT May Improve Sickle Cell Disease-Related Organ Dysfunction
A new analysis summarized evidence on the effects of allogeneic HSCT on SCD-related organ dysfunction in pediatric and adult patients with SCD.
Vadadustat Response Influenced by Patient Background in Anemia from CKD
A posthoc analysis of two phase 3 trials identified multiple independent factors associated with better response to vadadustat in patients with anemia.
Hemoglobin Levels Predict Renal Outcomes in Diabetic Kidney Disease
A study in China identified a negative and non-linear relationship between hemoglobin levels and a renal composite end point in patients with DKD.
Presence of CKD in Sickle Cell Disease Worsens In-Hospital Outcomes
Chronic kidney disease was linked to increased mortality, higher costs, and the need for mechanical ventilation among hospitalized patients with sickle cell disease.
RET-He Levels Detect Iron Deficiency in Acute Decompensated Heart Failure
Measurement of reticulocyte hemoglobin equivalent is cost-effective and could be a useful marker of iron deficiency in acute decompensated heart failure.
Substance Use Disorder of Nitrous Oxide Uncommon in Sickle Cell Disease
Results from the PHEDRE study show nitrous oxide in a gas mixture for pain was not problematic for most patients with sickle cell disease in France.
Iron Deficiency Linked to Poor Outcomes in Kidney Transplant Recipients
Iron deficiency, independent of anemia, may be a potentially modifiable target to improve patient-reported outcomes after kidney transplantation.
Anemia Exhibits Limited Association with Early Childhood Development
A cross-sectional analysis of nine low- and middle-income countries revealed few statistically significant associations between anemia and early childhood development.
Iptacopan Promotes Anemia Resolution in Paroxysmal Nocturnal Hemoglobinuria
Iptacopan monotherapy improved hematologic outcomes in both anti-C5–treated patients with persistent anemia and those not treated with complement inhibitors across two phase 3 trials.
Children with Sickle Cell Disease Experience Severe COVID-19 Infection
In a registry-based analysis, more hospitalized children with SCD and COVID-19 had severe infection requiring supplemental oxygen, compared with the general population.
CDC Opioid Guidelines Linked to Negative Consequences in Sickle Cell Disease
The 2016 CDC guidelines led to significant decreases in opioid prescriptions and an increase in pain-related healthcare utilization for people with sickle cell disease.
Thrombotic Adverse Events Frequent After Emicizumab for Hemophilia A
An analysis of an FDA adverse event database found thrombotic adverse events were more frequently reported with emicizumab than those of FVIII products.
Switch to Efmoroctocog Alfa May Lower Bleeding Events in Hemophilia A
Patients in France with hemophilia A who switched their FVIII replacement treatment trended towards fewer bleeding events and articular non-bleeding events requiring hospitalization.
Iron Deficiency Prevalent, Linked to Adverse Outcomes in Patients with HFrEF
Iron deficiency marks more than a comorbidity in heart failure, with adverse manifestations, including anemia and a higher risk of mortality, influencing the clinical trajectory of patients with HFrEF.
SGLT2 Inhibitor Use Lowers Anemia Risk in Patients with Diabetes, CKD
Initiation of SGLT2 inhibitors reduced the risk of composite anemia outcomes, compared with GLP-1 RA, among patients with type 2 diabetes and CKD.
Hematologic Parameters Predict Benefit of Baricitinib in COVID-19 Hospitalizations
In a post hoc analysis of the ACCT-2 study, a risk profile using simple hematologic parameters identified patients hospitalized with COVID-19 who benefited most from baricitinib treatment.
Quality Initiative Enhances Iron Deficiency Screening, Treatment in Heart Failure
Introduction of curated materials to assist clinicians was linked to better rates of screening and treatment of iron deficiency anemia among patients with heart failure.
Voxelotor Benefits Red Blood Cell Functionality in Pediatric Sickle Cell Disease
An ancillary study of the phase 2 HOPE-KIDS 1 trial revealed voxelotor is associated with reduced sickling and hemolysis in children with SCD.
Iron Deficiency Prevalent in Older Patients Admitted to Geriatric Units
More than half of older patients admitted to geriatric units in France had iron deficiency, including patients without anemia.
REVIVE: Rusfertide Effective for Erythrocytosis Control in Polycythemia Vera
Rusfertide maintained a hematocrit of <45% and reduced or eliminated the use of phlebotomy in patients with polycythemia vera.
Abnormal ECG Findings Prevalent Among People with Sickle Cell Disease
A meta-analysis revealed a higher prevalence of abnormal ECG findings in individuals with SCD compared to those without the disease.
Iron Isomaltoside Comparable to Iron Sucrose in Anemia Treatment
A meta-analysis of four RCTs found Iron isomaltoside ferumoxytol is both effective and safe to treat iron deficiency anemia.
Voxelotor Improves Cerebral Hemodynamic Parameters in Pediatric Sickle Cell Disease
Voxelotor decreases oxygen extraction fraction and cerebral blood flow towards levels observed in healthy children.
Children with Sickle Cell Disease Show No Alarming Trends After Opioid Use
No concerning patterns of long-term or increasing opioid use were observed within 3 years after first opioid prescription in opioid-naive children with SCD.
Hearing Loss Prevalence High in Children, Adults with Sickle Cell Disease
Hearing loss was more prevalent among children and adults with sickle cell disease and its traits compared to matched controls with normal hemoglobin.
Clinical Pain Screening Proves Feasible in Pediatric Sickle Cell Disease
Over the study period, pain screening procedures were integrated within routine clinical visits and providers’ workflow in sickle cell disease care.
Iron Deficiency Associated with Hearing Loss Risk in Adolescents
Microalbuminuria and low body iron levels displayed a significant association with pediatric hearing loss independently.
FDA Approves Iloprost Injection for Treatment of Severe Frostbite
The approval provides patients with the first-ever treatment option for severe frostbite to prevent the amputation of fingers or toes.
Mitapivat Sustains Reduction in Iron Burden in Pyruvate Kinase Deficiency
Mitapivat treatment was linked to long-term improvements in key markers of iron homeostasis and erythropoiesis in an analysis of the phase 3 ACTIVATE trial.
Iron Deficiency More Common in Preterm Infants Not Fed with Breast Milk
Non-breast milk-fed infants received more iron on average each day than breast-milk-fed infants, but experienced a higher rate of iron deficiency.